66102-69-0

Usage

Uses

Used in Pharmaceutical Industry:
3-amino-2-benzylpropan-1-ol is used as an intermediate in organic synthesis for the production of various pharmaceuticals, leveraging its chemical properties to contribute to the development of new medications.
Used in Medicinal Product Development:
It serves as an ingredient in the formulation of medicinal products due to its antibacterial and anti-inflammatory properties, enhancing the therapeutic effects of these products.
Used in Research and Development:
3-amino-2-benzylpropan-1-ol is utilized in research for its potential applications in treating neurological disorders and cancer, as it is studied for its effects on relevant biological pathways and mechanisms.
Used in Chemical Product Synthesis:
Beyond pharmaceuticals, 3-amino-2-benzylpropan-1-ol is also used as a building block in the synthesis of other chemical products, highlighting its versatility in the chemical industry.

Upstream product

• 6731-58-4 ethyl 2-cyano-3-phenylpropanoate 
• 2612-30-8 2-benzyl-1,3-propanediol 
• 2601-10-7 2‐benzyl‐3‐hydroxypropanenitrile 
• 98516-80-4 ethyl 2-formyl-3-phenylpropionate 
• 718633-37-5 methanesulfonic acid 2-phenylmethyl-3-(triethylsilyloxy)propyl ester 
• 718633-40-0 [(3-azido-2-phenylmethyl)propyloxy]triethylsilane 
• 718633-61-5 2-benzyl-3-triethylsilanyloxy-propan-1-ol 

Downstream Products

• 1142408-29-4 3-chloro-2-benzyl-1-propylamine 
• 718633-47-7 2-phenylmethyl-3-[4-methylphenylsulfonylamido]propanal 
• 718633-44-4 N-[(3-hydroxy-2-phenylmethyl)propyl]-4-methylbenzenesulfonamide 

Relevant academic research and scientific papers

Methods and compositions for treating amyloid-related diseases

Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease.

Stereoselective synthesis of 3-hydroxyproline benzyl esters from N-protected β-aminoaldehydes and benzyl diazoacetate

The synthesis of a series of 3-hydroxyproline benzyl esters from α-alkyl and α-alkoxy N-protected aminoaldehydes with benzyl diazoacetate is described. Aldehydes with α-alkyl substituents afforded prolines as a single diastereomer with a trans-cis relativ

Fused purine derivatives

A condensed purine derivative represented by Formula (I): wherein X—Y—Z represents R1N—C═O or N═C—W, R2 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted aromatic heterocyclic group, a substituted or unsubstituted alicyclic heterocyclic group or the like, n represents an integer of from 0 to 3, V1 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted aromatic heterocyclic group, V2 represents a substituted lower alkyl group or a substituted or unsubstituted aromatic heterocyclic group, and when V1 represents a hydrogen atom, a lower alkyl group, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group, and for example, X—Y—Z represents R1aN—C═O and R2 represents a substituted lower alkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted alicyclic heterocyclic group, a halogen atom, a lower alkylthio group, —NR7R8, —CO2H, a lower alkoxycarbonyl group, —COHal, —CONR9R10 or —CHO, V2 may represent a lower alkyl group, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group; or a pharmacologically acceptable salt thereof.

Method of producing γ-amino alcohols

A process for the production of γ-amino alcohols from β-dicarbonyl compounds is disclosed. The dicarbonyls are reacted with alkoxyamines and the resultant alkoximino compounds reduced to yield γ-amino alcohols. Also described are novel substituted γ-amino